Fusion Pharmaceuticals Inc.
FUSNDelisted Jun 5, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001805890
Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.
13F holders, Q2 2021
Institutional positions in Fusion Pharmaceuticals Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- +1 vs. Q1 2021
- Shares held
- 27.5M
- −119.1K (−0.4%) vs. Q1 2021
- Total value
- $221.8M
- −$74.1M (−25.0%) vs. Q1 2021
- New holders
- 5
- 15 more added
- Sold out
- 4
- 6 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FUSN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 114 | $1.47B |
| Q4 2023 | 77 | $584.1M |
| Q3 2023 | 41 | $129.8M |
| Q2 2023 | 41 | $235.1M |
| Q1 2023 | 38 | $171.9M |
| Q4 2022 | 30 | $88.9M |
| Q3 2022 | 34 | $80.3M |
| Q2 2022 | 31 | $69.4M |
| Q1 2022 | 28 | $219.1M |
| Q4 2021 | 32 | $116.0M |
| Q3 2021 | 40 | $220.6M |
| Q2 2021 | 39 | $221.8M |
| Q1 2021 | 38 | $295.9M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Fusion Pharmaceuticals Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 3,670,516 | $29.7M | 3.03% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,224,770 | $26.1M | 0.27% | 00.0% | Unchanged |
| FMR LLC | 3,184,209 | $25.7M | 0.00% | +45,821+1.5% | Added |
| Canada Pension Plan Investment Board | 3,116,966 | $25.2M | 0.03% | 00.0% | Unchanged |
| Adams Street Partners LLC | 2,973,744 | $24.0M | 4.99% | −15,900−0.5% | Reduced |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,551,794 | $20.6M | 0.15% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 1,775,167 | $14.3M | 0.19% | −175,000−9.0% | Reduced |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,598,377 | $12.6M | 4.97% | −20.0% | Reduced |
| Rock Springs Capital Management LP | 948,327 | $7.66M | 0.15% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 875,141 | $7.07M | 0.04% | +125,141+16.7% | Added |
| Artal Group S.A. | 750,000 | $6.06M | 0.14% | +210,736+39.1% | Added |
| 1832 Asset Management L.P. | 734,321 | $5.93M | 0.01% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 597,841 | $4.83M | 0.01% | +32,841+5.8% | Added |
| BlackRock Inc. | 470,303 | $3.80M | 0.00% | −337,233−41.8% | Reduced |
| Victory Capital Management Inc | 269,623 | $2.18M | 0.00% | −16,055−5.6% | Reduced |
| Sio Capital Management, LLC | 266,107 | $2.15M | 0.58% | +16,688+6.7% | Added |
| Woodline Partners LP | 154,597 | $1.25M | 0.02% | +30,003+24.1% | Added |
| Morgan Stanley | 76,212 | $615.0K | 0.00% | +41+0.1% | Added |
| Alyeska Investment Group, L.P. | 75,000 | $606.0K | 0.01% | 00.0% | Unchanged |
| AlphaCentric Advisors LLC | 71,500 | $578.0K | 0.16% | +34,500+93.2% | Added |
| Geode Capital Management, LLC | 23,089 | $186.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 18,221 | $147.0K | 0.00% | +4,149+29.5% | Added |
| HRT Financial LP | 14,180 | $114.0K | 0.00% | +14,180 | New |
| DekaBank Deutsche Girozentrale | 13,000 | $104.0K | 0.00% | 00.0% | Unchanged |
| Altfest L J & Co Inc | 10,213 | $83.0K | 0.02% | +74+0.7% | Added |
| UBS Group AG | 3,825 | $31.0K | 0.00% | +3,825 | New |
| Tower Research Capital LLC (TRC) | 3,015 | $24.0K | 0.00% | +1,457+93.5% | Added |
| Citigroup Inc | 2,574 | $21.0K | 0.00% | +1,777+223.0% | Added |
| Bank of America Corp | 2,325 | $18.0K | 0.00% | −19,298−89.2% | Reduced |
| JPMorgan Chase & Co | 2,043 | $17.0K | 0.00% | +2,019+8,412.5% | Added |
| Bank Julius Baer & Co. Ltd, Zurich | 1,980 | $16.0K | 0.00% | +1,980 | New |
| Simplex Trading, LLC | 1,308 | $10.0K | 0.00% | +1,308 | New |
| Royal Bank of Canada | 1,150 | $9.00K | 0.00% | +837+267.4% | Added |
| Penserra Capital Management LLC | 965 | $7.00K | 0.00% | +20+2.1% | Added |
| Signaturefd, LLC | 300 | $2.00K | 0.00% | 00.0% | Unchanged |
| Point72 Hong Kong Ltd | 240 | $2.00K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 78 | $1.00K | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 30 | $242 | 0.00% | 00.0% | Unchanged |
| Paragon Wealth Strategies, LLC | 18 | $0 | 0.00% | +18 | New |
| Vanguard Group Inc | 0 | $0 | 0.00% | −36,394−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −25,168−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −10,726−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,745−100.0% | Sold out |